AI-Powered Quantification for Myeloma WB-MRI – Publications
AI-Powered Quantification for Myeloma WB-MRI – Publications Protocol and acquisition Implementation of Whole-Body MRI (MY-RADS) within the OPTIMUM/MUKnine multi-centre clinical trial for…
From Theory to Practice: Evaluating g-values within mint Lesion
Following the FDA’s recent analysis of the growth rate constant (g) as a prognostic marker1, the challenge for many research organizations is implementation. mint Lesion provides a commercially…
Bridging the Gap Between RECIST and Survival: Why the FDA’s Analysis of the g Value is a Game-Changer
For decades, oncology trials have relied on RECIST 1.1 to evaluate drug efficacy. However, these categorical "snapshot" evaluations do not always correlate perfectly with Overall Survival (OS) or…
Update RSNA: Heart and Lung Imaging
Seminar in Radiological Diagnostics: "RSNA Update – Heart and Lung Imaging"